GlassScriptPhysician profile
Daniel Christian Murph
NPI 1578822052
$1,606.74
in general payments reported to CMS, 2019-2025
11 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $55.64 · 2021: $62.37 · 2022: $127 · 2023: $627 · 2024: $249 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $288.76 | 2022-2024 | Cerepak Uniform |
| Imperative Care, INC | $286.72 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom 7x Catheter |
| Route 92 Medical, INC. | $220.87 | 2024-2025 | 8f Base Camp Sheath System |
| Stryker Corporation | $205.47 | 2019-2024 | Surpass Evolve |
| Microvention, INC. | $188.64 | 2019-2023 | Stent, Web Aneurysm Embolization System |
| Astrazeneca Pharmaceuticals LP | $122.11 | 2023 | Andexxa |
| Penumbra, INC. | $85.42 | 2019-2025 | Penumbra System |
| Medtronic, INC. | $79.85 | 2021-2022 | |
| Cardiva Medical, INC. | $56.77 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Medtronic USA, INC. | $55.64 | 2020 | |
| Qapel Medical INC | $16.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Murph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.